Modelling G-protein-coupled receptors for drug design.

[1]  R C Brown,et al.  Dual D2-receptor and beta2-adrenoceptor agonists for the treatment of airway diseases. 1. Discovery and biological evaluation of some 7-(2-aminoethyl)-4-hydroxybenzothiazol-2(3H)-one analogues. , 1998, Journal of medicinal chemistry.

[2]  R. Hubbard,et al.  Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsin. , 1998, Journal of molecular biology.

[3]  M. Brann,et al.  Identification of a Ligand-dependent Switch within a Muscarinic Receptor* , 1998, The Journal of Biological Chemistry.

[4]  A. Patchett,et al.  Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential. , 1998, Journal of medicinal chemistry.

[5]  W. Dreyer,et al.  The area code hypothesis revisited: olfactory receptors and other related transmembrane receptors may function as the last digits in a cell surface code for assembling embryos. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  C. Humblet,et al.  G-Protein coupled receptors: models, mutagenesis, and drug design. , 1998, Journal of medicinal chemistry.

[7]  Robert J. Lefkowitz,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[8]  B. Kobilka,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[9]  R A Milligan,et al.  Lipid nanotubes as substrates for helical crystallization of macromolecules. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Bourne,et al.  G-protein diseases furnish a model for the turn-on switch , 1998, Nature.

[11]  Z. Shao,et al.  Submolecular resolution of single macromolecules with atomic force microscopy , 1998, FEBS letters.

[12]  D. Littman.  Chemokine Receptors: Keys to AIDS Pathogenesis? , 1998, Cell.

[13]  G. Vriend,et al.  G protein-coupled receptors in silico , 1998, Journal of Molecular Medicine.

[14]  T. Taverne,et al.  Novel benzothiazolin-2-one and benzoxazin-3-one arylpiperazine derivatives with mixed 5HT1A/D2 affinity as potential atypical antipsychotics. , 1998, Journal of medicinal chemistry.

[15]  Robert P. Millar,et al.  Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[16]  S. Rees,et al.  Agonist occupation of an alpha2A-adrenoreceptor-Gi1alpha fusion protein results in activation of both receptor-linked and endogenous Gi proteins. Comparisons of their contributions to GTPase activity and signal transduction and analysis of receptor-G protein activation stoichiometry. , 1998, The Journal of biological chemistry.

[17]  M. Filizola,et al.  A general procedure for building the transmembrane domains of G‐protein coupled receptors , 1998 .

[18]  Gerd Folkers,et al.  PrGen: Pseudoreceptor Modeling Using Receptor‐mediated Ligand Alignment and Pharmacophore Equilibration , 1998 .

[19]  P Burkhard,et al.  An example of a protein ligand found by database mining: description of the docking method and its verification by a 2.3 A X-ray structure of a thrombin-ligand complex. , 1998, Journal of molecular biology.

[20]  Juan Jesús Pérez,et al.  BUNDLE: A program for building the transmembrane domains of G-protein-coupled receptors , 1998, J. Comput. Aided Mol. Des..

[21]  K. Sandberg,et al.  Shared determinants of receptor binding for subtype selective, and dual endothelin‐angiotensin antagonists on the AT1 angiotensin II receptor , 1998, FEBS letters.

[22]  G Vriend,et al.  The interaction of class B G protein-coupled receptors with their hormones. , 1998, Receptors & channels.

[23]  H. Kikkawa,et al.  The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005. , 1998, Molecular pharmacology.

[24]  Terri K. Attwood,et al.  The PRINTS protein fingerprint database in its fifth year , 1998, Nucleic Acids Res..

[25]  G. Milligan,et al.  Measurement of agonist efficacy using an α2A‐adrenoceptor‐Gi1α fusion protein , 1997 .

[26]  C. Reynolds,et al.  A new approach to docking in the beta 2-adrenergic receptor that exploits the domain structure of G-protein-coupled receptors. , 1997, Journal of medicinal chemistry.

[27]  H Weinstein,et al.  Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenoceptor , 1997, The EMBO journal.

[28]  D. Bergsma,et al.  Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. , 1997, Trends in pharmacological sciences.

[29]  J. Tucker,et al.  Quantitative evaluation of neurotensin receptor purification by immobilized metal affinity chromatography. , 1997, Protein expression and purification.

[30]  P. Leff,et al.  A three-state receptor model of agonist action. , 1997, Trends in pharmacological sciences.

[31]  K. Marsh,et al.  Pyrrolidine-3-carboxylic acids as endothelin antagonists. 2. Sulfonamide-based ETA/ETB mixed antagonists. , 1997, Journal of medicinal chemistry.

[32]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[33]  E. Pebay-Peyroula,et al.  X-ray structure of bacteriorhodopsin at 2.5 angstroms from microcrystals grown in lipidic cubic phases. , 1997, Science.

[34]  Gebhard F. X. Schertler,et al.  Arrangement of rhodopsin transmembrane α-helices , 1997, Nature.

[35]  J. Alderfer,et al.  Three-dimensional structure of the cytoplasmic face of the G protein receptor rhodopsin. , 1997, Biochemistry.

[36]  Anton J. Hopfinger,et al.  Constructing Protein Models for Ligand-Receptor Binding Thermodynamic Simulations: An Application to a Set of Peptidometic Renin Inhibitors , 1997, J. Chem. Inf. Comput. Sci..

[37]  D Horvath,et al.  A virtual screening approach applied to the search for trypanothione reductase inhibitors. , 1997, Journal of medicinal chemistry.

[38]  T. Inagami,et al.  A review of mutagenesis studies of angiotensin II type 1 receptor, the three‐dimensional receptor model in search of the agonist and antagonist binding site and the hypothesis of a receptor activation mechanism , 1997, Journal of hypertension.

[39]  D. Donnelly.  The arrangement of the transmembrane helices in the secretin receptor family of G‐protein‐coupled receptors , 1997, FEBS letters.

[40]  D R Flower,et al.  ALTER: eclectic management of molecular structure data. , 1997, Journal of molecular graphics & modelling.

[41]  David Scott,et al.  The PRINTS Database of Protein Fingerprints: A Novel Information Resource for Computational Molecular Biology , 1997, J. Chem. Inf. Comput. Sci..

[42]  A. Lomize,et al.  The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. , 1997, Biophysical journal.

[43]  J. Wess.  G‐protein‐coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G‐protein recognition , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[44]  J. Alderfer,et al.  The first and second cytoplasmic loops of the G-protein receptor, rhodopsin, independently form beta-turns. , 1997, Biochemistry.

[45]  J. Spurlino,et al.  Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discovery. , 1997, Structure.

[46]  W. Greenlee,et al.  A nonpeptidic agonist ligand of the human C5a receptor: Synthesis, binding affinity optimization and functional characterization , 1997 .

[47]  J. Lubkowski,et al.  The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions , 1997, Nature Structural Biology.

[48]  Gerhard Klebe,et al.  What Can We Learn from Molecular Recognition in Protein–Ligand Complexes for the Design of New Drugs? , 1996 .

[49]  A. Beck‐Sickinger.  Structural characterization and binding sites of G-protein-coupled receptors , 1996 .

[50]  K. Sandberg,et al.  Interaction of biphenylimidazole and imidazoleacrylic acid nonpeptide antagonists with valine 108 in TM III of the AT1 angiotensin receptor , 1996, British journal of pharmacology.

[51]  S R Sprang,et al.  Structures of the extracellular domain of the type I tumor necrosis factor receptor. , 1996, Structure.

[52]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[53]  Wei Zheng,et al.  Identification of nonconserved amino acids in the AT1 receptor which comprise a general binding site for biphenylimidazole antagonists , 1996, FEBS letters.

[54]  G. Costantino,et al.  Homology modeling of metabotropic glutamate receptors. (mGluRs) structural motifs affecting binding modes and pharmacological profile of mGluR1 agonists and competitive antagonists. , 1996, Journal of medicinal chemistry.

[55]  S. Green,et al.  Sustained Activation of a G Protein-coupled Receptor via “Anchored” Agonist Binding , 1996, The Journal of Biological Chemistry.

[56]  Øyvind Edvardsen,et al.  A database of mutants and effects of site‐directed mutagenesis experiments on G protein‐coupled receptors , 1996, Proteins.

[57]  M. Johnson,et al.  Exosites: their current status, and their relevance to the duration of action of long-acting beta 2-adrenoceptor agonists. , 1996, Trends in pharmacological sciences.

[58]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[59]  A. IJzerman,et al.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[60]  Philip S. Portoghese,et al.  An Analysis of the Conserved Residues between Halobacterial Retinal Proteins and G-Protein Coupled Receptors: Implications for GPCR Modeling , 1996, J. Chem. Inf. Comput. Sci..

[61]  B. Gowen,et al.  Projection structure of an invertebrate rhodopsin. , 1996, Journal of structural biology.

[62]  Garland R. Marshall,et al.  VALIDATE: A New Method for the Receptor-Based Prediction of Binding Affinities of Novel Ligands , 1996 .

[63]  L. Hunyady,et al.  The ligand binding site of the angiotensin AT1 receptor. , 1996, Trends in pharmacological sciences.

[64]  T. Fong.  Mechanistic hypotheses for the activation of G-protein-coupled receptors. , 1996, Cellular signalling.

[65]  H. Hamm,et al.  The 2.0 Å crystal structure of a heterotrimeric G protein , 1996, Nature.

[66]  M C Peitsch,et al.  Automated modelling of the transmembrane region of G-protein coupled receptor by Swiss-model. , 1996, Receptors & channels.

[67]  D S Goodsell,et al.  Automated docking of flexible ligands: Applications of autodock , 1996, Journal of molecular recognition : JMR.

[68]  R. Graham,et al.  Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. , 1996, Molecular pharmacology.

[69]  P. Hargrave,et al.  Projection structure of frog rhodopsin in two crystal forms. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[70]  S. Karnik,et al.  Interaction of Phe8 of Angiotensin II with Lys199 and His256 of AT1 Receptor in Agonist Activation (*) , 1995, The Journal of Biological Chemistry.

[71]  P Herzyk,et al.  Automated method for modeling seven-helix transmembrane receptors from experimental data. , 1995, Biophysical journal.

[72]  J. Alderfer,et al.  Structure of the third cytoplasmic loop of bovine rhodopsin. , 1995, Biochemistry.

[73]  J. Alderfer,et al.  Structure of the carboxy-terminal domain of bovine rhodopsin , 1995, Nature Structural Biology.

[74]  Y. Sasaki,et al.  Novel deltorphin heptapeptide analogs with potent delta agonist, delta antagonist, or mixed mu antagonist/delta agonist properties. , 1995, Journal of medicinal chemistry.

[75]  K. Catt,et al.  Genetic transfer of a nonpeptide antagonist binding site to a previously unresponsive angiotensin receptor. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[76]  C. Tate,et al.  Overexpression of integral membrane proteins for structural studies , 1995, Quarterly Reviews of Biophysics.

[77]  R. Wade,et al.  Prediction of drug binding affinities by comparative binding energy analysis , 1995 .

[78]  Yoshihisa Inoue,et al.  Mutagenesis and the Molecular Modeling of the Rat Angiotensin II Receptor (AT1) (*) , 1995, The Journal of Biological Chemistry.

[79]  N. Sepetov,et al.  Library of libraries: approach to synthetic combinatorial library design and screening of "pharmacophore" motifs. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[80]  C. Strader,et al.  The family of G‐protein‐coupled receptors , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  S. Karnik,et al.  The Docking of Arg2 of Angiotensin II with Asp281 of AT1 Receptor Is Essential for Full Agonism (*) , 1995, The Journal of Biological Chemistry.

[82]  G. Schertler,et al.  Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. , 1995, Biophysical journal.

[83]  D C Spellmeyer,et al.  Measuring diversity: experimental design of combinatorial libraries for drug discovery. , 1995, Journal of medicinal chemistry.

[84]  T. Schwartz,et al.  Interaction between the nonpeptide angiotensin antagonist SKF-108,566 and histidine 256 (HisVI:16) of the angiotensin type 1 receptor. , 1995, Molecular pharmacology.

[85]  R. Graham,et al.  Tetrazole and Carboxylate Groups of Angiotensin Receptor Antagonists Bind to the Same Subsite by Different Mechanisms (*) , 1995, The Journal of Biological Chemistry.

[86]  W. Greenlee,et al.  Non-peptide Angiotensin Agonist , 1995, The Journal of Biological Chemistry.

[87]  G M Shepherd,et al.  Potential ligand-binding residues in rat olfactory receptors identified by correlated mutation analysis. , 1995, Receptors & channels.

[88]  W. Greenlee,et al.  Identification of peptide binding residues in the extracellular domains of the AT1 receptor. , 1994, The Journal of biological chemistry.

[89]  K Prendergast,et al.  Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. , 1994, Chemistry & biology.

[90]  D. Kocjan.  On the interaction of the aromatic part of dopaminergic agonists with the receptor. , 1994, Journal of medicinal chemistry.

[91]  T. Schwartz,et al.  Locating ligand-binding sites in 7TM receptors by protein engineering. , 1994, Current opinion in biotechnology.

[92]  C. Strader,et al.  Functional mapping of the ligand binding sites of G‐Protein coupled receptors , 1994, Medicinal research reviews.

[93]  Yue Zhang,et al.  Differential structural requirements for specific binding of nonpeptide and peptide antagonists to the AT1 angiotensin receptor. Identification of amino acid residues that determine binding of the antihypertensive drug losartan. , 1994, The Journal of biological chemistry.

[94]  D. C. Harris,et al.  Crystal structure of human chorionic gonadotropin , 1994, Nature.

[95]  S. Watson,et al.  The G-Protein Linked Receptor Facts Book , 1994 .

[96]  P. Evans,et al.  Agonist‐specific coupling of a cloned Drosophila octopamine/tyramine receptor to multiple second messenger systems. , 1994, The EMBO journal.

[97]  T K Attwood,et al.  Fingerprinting G-protein-coupled receptors. , 1994, Protein engineering.

[98]  Kolakowski Lf.  GCRDB: A G-PROTEIN-COUPLED RECEPTOR DATABASE , 1994 .

[99]  C. Strader,et al.  Structure and function of G protein-coupled receptors. , 1994, Annual review of biochemistry.

[100]  J Hoflack,et al.  Re-evaluation of bacteriorhodopsin as a model for G protein-coupled receptors. , 1994, Trends in pharmacological sciences.

[101]  D R Flower,et al.  Structural relationship of streptavidin to the calycin protein superfamily , 1993, FEBS letters.

[102]  I. Kuntz,et al.  Matching chemistry and shape in molecular docking. , 1993, Protein engineering.

[103]  G. Schulz,et al.  STRUCTURE OF PORIN REFINED AT 1.8 ANGSTROMS RESOLUTION , 1993 .

[104]  B. Kobilka,et al.  Amino acid substitutions at position 312 in the seventh hydrophobic segment of the beta 2-adrenergic receptor modify ligand-binding specificity. , 1993, Molecular pharmacology.

[105]  T. Attwood,et al.  Structure and sequence relationships in the lipocalins and related proteins , 1993, Protein science : a publication of the Protein Society.

[106]  J. Baldwin.  The probable arrangement of the helices in G protein‐coupled receptors. , 1993, The EMBO journal.

[107]  I. Kuntz,et al.  Structure-based discovery of inhibitors of thymidylate synthase. , 1993, Science.

[108]  T K Attwood,et al.  Design of a discriminating fingerprint for G-protein-coupled receptors. , 1993, Protein engineering.

[109]  A. Vedani,et al.  Pseudo-receptor modeling: a new concept for the three-dimensional construction of receptor binding sites. , 1993, Journal of receptor research.

[110]  S. Trumpp-Kallmeyer,et al.  This is not a G protein-coupled receptor. , 1993, Trends in pharmacological sciences.

[111]  X. Lewell.  A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. , 1993, Drug design and discovery.

[112]  S. Chaki,et al.  Identification of amino acid residues of rat angiotensin II receptor for ligand binding by site directed mutagenesis. , 1992, Biochemical and biophysical research communications.

[113]  G. Schulz,et al.  Structure of porin refined at 1.8 A resolution. , 1992, Journal of molecular biology.

[114]  G M Maggiora,et al.  An energy‐based approach to packing the 7‐helix bundle of bacteriorhodopsin , 1992, Protein science : a publication of the Protein Society.

[115]  E. Wong,et al.  Spiropiperidines as high-affinity, selective sigma ligands. , 1992, Journal of medicinal chemistry.

[116]  L. Pardo,et al.  On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[117]  C. Fraser,et al.  In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. , 1992, The Biochemical journal.

[118]  W. Kühlbrandt,et al.  Two-dimensional crystallization of membrane proteins , 1992, Quarterly Reviews of Biophysics.

[119]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[120]  I. Sylte,et al.  Molecular dynamics of dopamine at the D2 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[121]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[122]  T. Attwood,et al.  Multiple sequence alignment of protein families showing low sequence homology: a methodological approach using database pattern-matching discriminators for G-protein-linked receptors. , 1991, Gene.

[123]  C. Strader,et al.  Biophysical and genetic analysis of the ligand-binding site of the beta-adrenoceptor. , 1991, Trends in pharmacological sciences.

[124]  E. Eliopoulos,et al.  Three-dimensional modelling of G protein-linked receptors. , 1990, Trends in pharmacological sciences.

[125]  C. Strader,et al.  Characterization of the binding domain of the beta-adrenergic receptor with the fluorescent antagonist carazolol. Evidence for a buried ligand binding site. , 1990, The Journal of biological chemistry.

[126]  Richard Henderson,et al.  A model for the structure of bacteriorhodopsin based on high resolution electron cryomicroscopy , 1990 .

[127]  R. Henderson,et al.  Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. , 1990, Journal of molecular biology.

[128]  R Henderson,et al.  The structure of bacteriorhodopsin and its relevance to the visual opsins and other seven-helix G-protein coupled receptors. , 1990, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[129]  C. Strader,et al.  A single amino acid substitution in the beta-adrenergic receptor promotes partial agonist activity from antagonists. , 1989, The Journal of biological chemistry.

[130]  C. Strader,et al.  Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor. , 1989, The Journal of biological chemistry.

[131]  C. Strader,et al.  Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[132]  B. E. Evans,et al.  Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. , 1988, Journal of medicinal chemistry.

[133]  C. Strader,et al.  Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function. , 1988, The Journal of biological chemistry.

[134]  C. Strader,et al.  Identification of residues required for ligand binding to the beta-adrenergic receptor. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[135]  Irving S. Sigal,et al.  Ligand binding to the β-adrenergic receptor involves its rhodopsin-like core , 1987, Nature.

[136]  J. Deisenhofer,et al.  Structure of the protein subunits in the photosynthetic reaction centre of Rhodopseudomonas viridis at 3Å resolution , 1985, Nature.

[137]  A. Lesk,et al.  How different amino acid sequences determine similar protein structures: the structure and evolutionary dynamics of the globins. , 1980, Journal of molecular biology.